SEMI-FLEXIBLE HAMMERTOE

Clinical trials for SEMI-FLEXIBLE HAMMERTOE explained in plain language.

Never miss a new study

Get alerted when new SEMI-FLEXIBLE HAMMERTOE trials appear

Sign up with your email to follow new studies for SEMI-FLEXIBLE HAMMERTOE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could a single injection replace surgery for hammertoes?

Disease control Not yet recruiting

This Phase 3 trial tests an injectable treatment called KN3835 against a placebo in about 554 people with flexible or semi-flexible hammertoes. The goal is to see if KN3835 can reduce the toe's bending and improve foot function and pain. Participants receive either the treatment …

Matched conditions: SEMI-FLEXIBLE HAMMERTOE

Phase: PHASE3 • Sponsor: Endo USA Inc., a Keenova Therapeutics Company • Aim: Disease control

Last updated Aug 14, 2026 00:00 UTC

SEMI-FLEXIBLE HAMMERTOE

Get alerted when new SEMI-FLEXIBLE HAMMERTOE trials appear

Could a single injection replace surgery for hammertoes?